Terms: = Cervical cancer AND HSP90AA1, ENSG00000080824, 3320, P07900, LAP2, HSPN, HSPCAL4, HSPCAL1, HSPCA, HSPC1, HSP90N, HSP90A, Hsp90, Hsp89, HSP86, FLJ31884 AND Treatment
23 results:
1. Study on the mechanism of Shujin Tongluo granules in treating cervical spondylosis based on network pharmacology and molecular docking.
Wang Y; Tao X; Gao Y; Jin Z; Guo S; Li Z; Wang M; Zhao R; Zhou W; Wu J
Medicine (Baltimore); 2023 Jul; 102(29):e34030. PubMed ID: 37478234
[TBL] [Abstract] [Full Text] [Related]
2. The effects of STA-9090 (Ganetespib) and venetoclax (ABT-199) combination on apoptotic pathways in human cervical cancer cells.
Karademir D; Özgür A
Med Oncol; 2023 Jul; 40(8):234. PubMed ID: 37432531
[TBL] [Abstract] [Full Text] [Related]
3. Bioinformatics Analysis of Novel Targets for Treating cervical cancer by Immunotherapy Based on Immune Escape.
Han YH; Ma DY; Lee SJ; Mao YY; Sun SY; Jin MH; Sun HN; Kwon T
Cancer Genomics Proteomics; 2023; 20(4):383-397. PubMed ID: 37400149
[TBL] [Abstract] [Full Text] [Related]
4. Disulfiram suppresses epithelial-mesenchymal transition (EMT), migration and invasion in cervical cancer through the hsp90a/NDRG1 pathway.
Zheng P; Wu Y; Wang Y; Hu F
Cell Signal; 2023 Sep; 109():110771. PubMed ID: 37329997
[TBL] [Abstract] [Full Text] [Related]
5. Integrating network pharmacology approaches for the investigation of multi-target pharmacological mechanism of 6-shogaol against cervical cancer.
Elasbali AM; Al-Soud WA; Mousa Elayyan AE; Al-Oanzi ZH; Alhassan HH; Mohamed BM; Alanazi HH; Ashraf MS; Moiz S; Patel M; Patel M; Adnan M
J Biomol Struct Dyn; 2023; 41(23):14135-14151. PubMed ID: 36943780
[TBL] [Abstract] [Full Text] [Related]
6. Robot-assisted versus laparoscopic minimally invasive surgery for the treatment of stage I endometrial cancer.
Argenta PA; Mattson J; Rivard CL; Luther E; Schefter A; Vogel RI
Gynecol Oncol; 2022 May; 165(2):347-352. PubMed ID: 35314086
[TBL] [Abstract] [Full Text] [Related]
7. hsp90 promotes radioresistance of cervical cancer cells via reducing FBXO6-mediated CD147 polyubiquitination.
Song Q; Wen J; Li W; Xue J; Zhang Y; Liu H; Han J; Ning T; Lu Z
Cancer Sci; 2022 Apr; 113(4):1463-1474. PubMed ID: 35043518
[TBL] [Abstract] [Full Text] [Related]
8. hsp90 Inhibitor SNX-2112 Enhances TRAIL-Induced Apoptosis of Human cervical cancer Cells via the ROS-Mediated JNK-p53-Autophagy-DR5 Pathway.
Hu L; Wang Y; Chen Z; Fu L; Wang S; Zhang X; Zhang P; Lu X; Jie H; Li M; Wang Y; Liu Z
Oxid Med Cell Longev; 2019; 2019():9675450. PubMed ID: 31019655
[TBL] [Abstract] [Full Text] [Related]
9. Radiation sensitivity assay with a panel of patient-derived spheroids of small cell carcinoma of the cervix.
Nakajima A; Endo H; Okuyama H; Kiyohara Y; Kimura T; Kamiura S; Hiraoka M; Inoue M
Int J Cancer; 2015 Jun; 136(12):2949-60. PubMed ID: 25408479
[TBL] [Abstract] [Full Text] [Related]
10. Heat shock protein 90 inhibitor mycoepoxydiene modulates kinase signaling in cervical cancer cells and inhibits in-vivo tumor growth.
Lin P; Yi Y; Lu M; Wang M; Yang Y; Lu Y; Song S; Zheng Z; Deng X; Zhang L
Anticancer Drugs; 2015 Jan; 26(1):25-34. PubMed ID: 25014191
[TBL] [Abstract] [Full Text] [Related]
11. Bag-1L is a stress-withstand molecule prevents the downregulation of Mcl-1 and c-Raf under control of heat shock proteins in cisplatin treated HeLa cervix cancer cells.
Ozfiliz P; Arisan ED; Coker-Gurkan A; Obakan P; Eralp TN; Dinler-Doganay G; Palavan-Unsal N
Asian Pac J Cancer Prev; 2014; 15(11):4475-82. PubMed ID: 24969872
[TBL] [Abstract] [Full Text] [Related]
12. Stressing the ubiquitin-proteasome system without 20S proteolytic inhibition selectively kills cervical cancer cells.
Anchoori RK; Khan SR; Sueblinvong T; Felthauser A; Iizuka Y; Gavioli R; Destro F; Isaksson Vogel R; Peng S; Roden RB; Bazzaro M
PLoS One; 2011; 6(8):e23888. PubMed ID: 21909374
[TBL] [Abstract] [Full Text] [Related]
13. [Effect of heat shock protein 90 inhibitor 17-dimethylamino-ethylaminogeldanamycin on TNfalpha-mediated apoptosis and TNF-induced NF-kappaB activation].
Zhong YJ; Wang X; Zheng XL; Yan YY; Liu XM; Liao LC
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 May; 42(3):303-7. PubMed ID: 21826987
[TBL] [Abstract] [Full Text] [Related]
14. Pharmacological inhibition of hsp90 as a novel antitumor strategy to target cytoarchitecture through extracellular matrix signaling.
Chaturvedi V; Kumar JU; Paithankar KR; Vanathi P; Sreedhar AS
Med Chem; 2011 Sep; 7(5):454-65. PubMed ID: 21801149
[TBL] [Abstract] [Full Text] [Related]
15. hsp90 inhibitor-mediated disruption of chaperone association of ATR with hsp90 sensitizes cancer cells to DNA damage.
Ha K; Fiskus W; Rao R; Balusu R; Venkannagari S; Nalabothula NR; Bhalla KN
Mol Cancer Ther; 2011 Jul; 10(7):1194-206. PubMed ID: 21566061
[TBL] [Abstract] [Full Text] [Related]
16. Targeting focal adhesion kinase with dominant-negative FRNK or hsp90 inhibitor 17-DMAG suppresses tumor growth and metastasis of SiHa cervical xenografts.
Schwock J; Dhani N; Cao MP; Zheng J; Clarkson R; Radulovich N; Navab R; Horn LC; Hedley DW
Cancer Res; 2009 Jun; 69(11):4750-9. PubMed ID: 19458065
[TBL] [Abstract] [Full Text] [Related]
17. Efficacy of hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo.
Schwock J; Pham NA; Cao MP; Hedley DW
Cancer Chemother Pharmacol; 2008 Apr; 61(4):669-81. PubMed ID: 17579866
[TBL] [Abstract] [Full Text] [Related]
18. Analysis of hypoxia-inducible factor-1alpha accumulation and cell cycle in geldanamycin-treated human cervical carcinoma cells by laser scanning cytometry.
Schwock J; Geddie WR; Hedley DW
Cytometry A; 2005 Dec; 68(2):59-70. PubMed ID: 16228978
[TBL] [Abstract] [Full Text] [Related]
19. 17-Allyamino-17-demethoxygeldanamycin and 17-NN-dimethyl ethylene diamine-geldanamycin have cytotoxic activity against multiple gynecologic cancer cell types.
Gossett DR; Bradley MS; Jin X; Lin J
Gynecol Oncol; 2005 Feb; 96(2):381-8. PubMed ID: 15661225
[TBL] [Abstract] [Full Text] [Related]
20. A proteomic approach to cisplatin resistance in the cervix squamous cell carcinoma cell line A431.
Castagna A; Antonioli P; Astner H; Hamdan M; Righetti SC; Perego P; Zunino F; Righetti PG
Proteomics; 2004 Oct; 4(10):3246-67. PubMed ID: 15378690
[TBL] [Abstract] [Full Text] [Related]
[Next]
